MAXWELL TECHNOLOGIES INC, 10-Q filed on 8/2/2012
Quarterly Report
Document and Entity Information
6 Months Ended
Jun. 30, 2012
Jul. 26, 2012
Document and Entity Information [Abstract]
 
 
Entity Registrant Name
MAXWELL TECHNOLOGIES INC 
 
Entity Central Index Key
0000319815 
 
Document Type
10-Q 
 
Document Period End Date
Jun. 30, 2012 
 
Amendment Flag
false 
 
Document Fiscal Year Focus
2012 
 
Document Fiscal Period Focus
Q2 
 
Trading Symbol
mxwl 
 
Current Fiscal Year End Date
--12-31 
 
Entity Filer Category
Accelerated Filer 
 
Entity Common Stock, Shares Outstanding
 
29,196,307 
Condensed Consolidated Balance Sheets (Unaudited) (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2012
Dec. 31, 2011
Current assets :
 
 
Cash and cash equivalents
$ 22,310 
$ 29,289 
Trade and other accounts receivable, net of allowance for doubtful accounts of $216 and $577 at June 30, 2012 and December 31, 2011, respectively
48,514 
36,131 
Inventories
30,217 
27,232 
Prepaid expenses and other current assets
3,299 
3,125 
Total current assets
104,340 
95,777 
Property and equipment, net
33,275 
28,541 
Intangible assets, net
854 
1,111 
Goodwill
24,621 
24,887 
Pension asset
6,685 
6,359 
Other non-current assets
94 
261 
Total assets
169,869 
156,936 
Current liabilities:
 
 
Accounts payable and accrued liabilities
32,301 
37,145 
Accrued warranty
265 
258 
Accrued employee compensation
5,721 
6,243 
Short-term borrowings and current portion of long-term debt
6,870 
5,431 
Deferred tax liability
499 
499 
Total current liabilities
45,656 
49,576 
Deferred tax liability, long-term
952 
933 
Long-term debt, excluding current portion
3,389 
68 
Other long-term liabilities
750 
3,028 
Total liabilities
50,747 
53,605 
Commitments and contingencies (Note 10)
   
   
Stockholders' equity:
 
 
Common stock, $0.10 par value per share, 40,000 shares authorized; 29,136 and 28,174 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively
2,911 
2,815 
Additional paid-in capital
266,225 
252,907 
Accumulated deficit
(159,860)
(163,021)
Accumulated other comprehensive income
9,846 
10,630 
Total stockholders' equity
119,122 
103,331 
Total liabilities and stockholders' equity
$ 169,869 
$ 156,936 
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)
In Thousands, except Per Share data, unless otherwise specified
Jun. 30, 2012
Dec. 31, 2011
Condensed Consolidated Balance Sheets [Abstract]
 
 
Trade and other accounts receivable, allowance
$ 216 
$ 577 
Common stock, par value
$ 0.10 
$ 0.10 
Common stock, shares authorized
40,000 
40,000 
Common stock, shares issued
29,136 
28,174 
Common stock, shares outstanding
29,136 
28,174 
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Condensed Consolidated Statements of Operations [Abstract]
 
 
 
 
Revenue
$ 40,856 
$ 38,463 
$ 80,086 
$ 73,722 
Cost of revenue
23,876 
22,987 
46,969 
44,362 
Gross profit
16,980 
15,476 
33,117 
29,360 
Operating expenses:
 
 
 
 
Selling, general and administrative
8,187 
11,747 
17,422 
19,681 
Research and development
5,294 
5,297 
10,890 
11,269 
Amortization of intangibles
51 
51 
102 
102 
Total operating expenses
13,532 
17,095 
28,414 
31,052 
Income (loss) from operations
3,448 
(1,619)
4,703 
(1,692)
Interest expense, net
(56)
(25)
(82)
(61)
Amortization of debt discount and prepaid debt costs
(15)
 
(26)
(55)
Gain on embedded derivatives
 
 
 
1,086 
Income (loss) from operations before income taxes
3,377 
(1,644)
4,595 
(722)
Income tax provision (benefit)
719 
(427)
1,433 
299 
Net income (loss)
$ 2,658 
$ (1,217)
$ 3,162 
$ (1,021)
Net income (loss) per share:
 
 
 
 
Basic
$ 0.09 
$ (0.04)
$ 0.11 
$ (0.04)
Diluted
$ 0.09 
$ (0.04)
$ 0.11 
$ (0.04)
Weighted average common shares outstanding:
 
 
 
 
Basic
28,672 
27,669 
28,397 
27,478 
Diluted
28,780 
27,669 
28,680 
27,478 
Condensed Consolidated Statements of Comprehensive Income Loss (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Condensed Consolidated Statements of Comprehensive Income [Abstract]
 
 
 
 
Net income (loss)
$ 2,658 
$ (1,217)
$ 3,162 
$ (1,021)
Other comprehensive income (loss), net of tax:
 
 
 
 
Foreign currency translation adjustment
(3,347)
5,308 
(894)
6,060 
Defined benefit pension plan, net of tax:
 
 
 
 
Amortization of deferred loss, net of tax of $8 and $0 for the three months ended June 30, 2012 and 2011, respectively; net of tax of $16 and $0 for the six months ended June 30, 2012 and 2011, respectively
46 
79 
92 
152 
Amortization of prior service cost, net of tax of $2 and $0 for the three months ended June 30, 2012 and 2011, respectively; net of tax of $4 and $0 for the six months ended June 30, 2012 and 2011, respectively
11 
18 
22 
Other comprehensive income (loss), net of tax
(3,292)
5,398 
(784)
6,234 
Comprehensive income (loss)
$ (634)
$ 4,181 
$ 2,378 
$ 5,213 
Condensed Consolidated Statements of Comprehensive Income Loss (Unaudited) (Parenthetical) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Condensed Consolidated Statements of Comprehensive Income [Abstract]
 
 
 
 
Net of tax on net income (loss)
$ 8 
$ 0 
$ 16 
$ 0 
Net of tax on prior service credit (cost)
$ 2 
$ 0 
$ 4 
$ 0 
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
OPERATING ACTIVITIES:
 
 
Net income (loss)
$ 3,162 
$ (1,021)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
 
 
Depreciation
3,394 
3,095 
Amortization of intangible assets
254 
275 
Amortization of debt discount and prepaid debt costs
26 
55 
Gain on embedded derivatives and warrants
 
(1,086)
Pension cost
91 
120 
Stock-based compensation expense
2,056 
1,706 
Provision for (recovery of) losses on accounts receivable
(362)
203 
Changes in operating assets and liabilities:
 
 
Trade and other accounts receivable
(12,160)
(7,628)
Inventories
(3,031)
(7,098)
Prepaid expenses and other assets
(32)
303 
Accounts payable and accrued liabilities
(4,672)
3,167 
Accrued employee compensation
(504)
688 
Deferred tax liability, long term
19 
 
Other long-term liabilities
(2,275)
(5,567)
Net cash used in operating activities
(14,034)
(12,788)
INVESTING ACTIVITIES:
 
 
Purchase of property and equipment
(8,288)
(7,291)
Net cash used in investing activities
(8,288)
(7,291)
FINANCING ACTIVITIES:
 
 
Principal payments on long-term debt and short-term borrowings
(3,363)
(6,650)
Proceeds from long-term and short-term borrowings
8,161 
6,472 
Proceeds from sale of common stock, net of proceeds
10,283 
 
Repurchase of shares
(319)
(121)
Proceeds from issuance of common stock under equity compensation plans
1,393 
1,061 
Release of restricted cash
 
8,000 
Net cash provided by financing activities
16,155 
8,762 
Effect of exchange rate changes on cash and cash equivalents
(812)
1,279 
Decrease in cash and cash equivalents
(6,979)
(10,038)
Cash and cash equivalents, beginning of period
29,289 
39,829 
Cash and cash equivalents, end of period
$ 22,310 
$ 29,791 
Description of Business and Basis of Presentation
Description of Business and Basis of Presentation

Note 1 – Description of Business and Basis of Presentation

Description of Business

Maxwell Technologies, Inc. is a Delaware corporation originally incorporated in 1965 under the name Maxwell Laboratories, Inc. In 1983, the Company completed an initial public offering, and in 1996, changed its name to Maxwell Technologies, Inc. The Company is headquartered in San Diego, California and has two manufacturing locations, in San Diego, California and Rossens, Switzerland, and is in the process of opening a manufacturing facility in Peoria, Arizona. In addition, the Company has two contract manufacturers located in China. Maxwell operates as one operating segment called High Reliability, which is comprised of three product lines:

 

   

Ultracapacitors: The Company’s primary focus, ultracapacitors, are energy storage devices that possess a unique combination of high power density, extremely long operational life and the ability to charge and discharge very rapidly. The Company’s ultracapacitor cells and multi-cell packs and modules provide highly reliable energy storage and power delivery solutions for applications in multiple industries, including transportation, automotive, information technology, renewable energy and consumer and industrial electronics.

 

   

High-Voltage Capacitors: The Company’s CONDIS ® high-voltage capacitors are extremely robust devices that are designed and manufactured to perform reliably for decades. These products include grading and coupling capacitors and capacitive voltage dividers that are used to ensure the safety and reliability of electric utility infrastructure and other applications involving transport, distribution and measurement of high-voltage electrical energy.

 

   

Radiation-Hardened Microelectronic Products: The Company’s radiation-hardened microelectronic products include high-performance, high-density power modules, memory modules and single board computers that incorporate our proprietary RADPAK® packaging and shielding technology and novel architectures that enable them to withstand environmental radiation effects and perform reliably in space.

The Company’s products are designed to perform reliably for the life of the products and systems into which they are integrated. The Company achieves high reliability through the application of proprietary technologies and rigorously controlled design, development, manufacturing and test processes.

Financial Statement Presentation

The accompanying condensed consolidated financial statements include the accounts of Maxwell Technologies, Inc. and its subsidiaries. All significant intercompany transactions and account balances have been eliminated in consolidation. The Company has prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with the instructions to Form 10-Q and the standards of accounting measurement set forth in the Interim Reporting Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”). Consequently, the Company has not necessarily included in this Form 10-Q all information and footnotes required for audited financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements in this Form 10-Q contain all adjustments (consisting only of normal recurring adjustments, except as otherwise indicated) necessary to present fairly the financial position, results of operations, and cash flows of Maxwell Technologies, Inc. for all periods presented. The results reported in these condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for any subsequent period or for the entire year. These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and the notes thereto included in the Company’s latest Annual Report on Form 10-K. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted in the accompanying interim consolidated financial statements. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts and related disclosures. These estimates include, but are not limited to, assessing the collectability of accounts receivable, applied and unapplied production costs, production capacities, the usage and recoverability of inventories and long-lived assets, including deferred income taxes, the incurrence of warranty obligations, impairment of goodwill and other intangible assets, estimation of the cost to complete certain projects, accruals for estimated losses from legal matters, and estimation of the value of stock-based compensation awards, including the probability that the performance criteria of restricted stock awards will be met.

 

Warranty Obligation

The Company provides warranties on all product sales. The majority of the Company’s warranties are for one to two years in the normal course of business. The Company accrues for the estimated warranty costs at the time of sale based on historical warranty experience plus any known or expected changes in warranty exposure.

Net Income (Loss) per Share

In accordance with the Earnings Per Share Topic of the FASB ASC, basic net income (loss) per share is calculated using the weighted average number of common shares outstanding during the period. Diluted net income per share includes the impact of additional common shares that would have been outstanding if potentially dilutive common shares were issued. Potentially dilutive securities are not considered in the calculation of diluted net loss per share, as their inclusion would be anti-dilutive. The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share data):

 

                                 
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2012     2011     2012     2011  

Numerator

                               

Net income (loss)

  $ 2,658     $ (1,217   $ 3,162     $ (1,021

Denominator

                               

Weighted-average common shares outstanding

    28,672       27,669       28,397       27,478  

Effect of potentially dilutive securities:

                               

Options to purchase common stock

    85       —         223       —    

Restricted stock awards

    5       —         23       —    

Restricted stock unit awards

    —         —         4       —    

Employee stock purchase plan

    18       —         33       —    
   

 

 

   

 

 

   

 

 

   

 

 

 

Weighted-average common shares outstanding, assuming dilution

    28,780       27,669       28,680       27,478  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per share

                               

Basic

  $ 0.09     $ (0.04   $ 0.11     $ (0.04

Diluted

  $ 0.09     $ (0.04   $ 0.11     $ (0.04

The following table summarizes instruments that may be convertible into common shares that are not included in the denominator used in the diluted net income (loss) per share calculation because to do so would be anti-dilutive (in thousands):

 

                                 
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2012     2011     2012     2011  

Outstanding options to purchase common stock

    637       1,404       318       1,404  

Restricted stock awards

    340       259       238       259  

Restricted stock unit awards

    21       22       —         22  

Employee stock purchase plan

    —         19       —         19  

Change in Additional Paid in Capital

For the six months ended June 30, 2012, additional paid in capital increased $13.3 million. This increase includes $10.2 million related to proceeds from shares of common stock sold pursuant to the Company’s shelf registration statement, net of offering costs, and $3.4 million associated with the Company’s stock-based compensation plans, offset by $318,000 for the repurchase of shares that were withheld by the Company to satisfy employee tax liabilities upon the vesting of restricted stock awards.

Pending Accounting Pronouncements

In December 2011, the FASB issued Accounting Standards Update No. 2011-11, Balance Sheet (Topic 210), Disclosures about Offsetting Assets and Liabilities, which requires companies to disclose information about financial instruments that have been offset and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. Companies will be required to provide both net (offset amounts) and gross information in the notes to the financial statements for relevant assets and liabilities that are offset. This standard will be effective for fiscal years, and interim periods within those years, beginning on or after January 1, 2013. The Company does not expect the adoption of the standard update to impact its financial position or results of operations, as it only requires additional disclosure in the Company’s financial statements.

Balance Sheet Details
Balance Sheet Details

Note 2 – Balance Sheet Details (in thousands)

Inventories

 

                 
    June 30,
2012
    December 31,
2011
 

Raw material and purchased parts

  $ 12,159     $ 10,361  

Work-in-process

    3,014       3,552  

Finished goods

    15,044       13,319  
   

 

 

   

 

 

 

Total inventories

  $ 30,217     $ 27,232  
   

 

 

   

 

 

 

Intangible Assets

Intangible assets consisted of the following:

 

                                 
    Gross
Carrying
Value
    Accumulated
Amortization
    Foreign
Currency
Adjustment
    Net
Carrying
Value
 

As of June 30, 2012:

                               

Patents

  $ 2,476     $ (1,802   $ —       $ 674  

Developed core technology

    1,100       (1,393     299       6  

Patent license agreement

    741       (572     5       174  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total intangible assets at June 30, 2012

  $ 4,317     $ (3,767   $ 304     $ 854  
   

 

 

   

 

 

   

 

 

   

 

 

 
         
    Gross
Carrying
Value
    Accumulated
Amortization
    Foreign
Currency
Adjustment
    Net
Carrying
Value
 

As of December 31, 2011:

                               

Patents

  $ 2,476     $ (1,699   $ —       $ 777  

Developed core technology

    1,100       (1,325     304       79  

Patent license agreement

    741       (494     8       255  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total intangible assets at December 31, 2011

  $ 4,317     $ (3,518   $ 312     $ 1,111  
   

 

 

   

 

 

   

 

 

   

 

 

 

Goodwill

The change in the carrying amount of goodwill from December 31, 2011 to June 30, 2012 is as follows:

 

         

Balance at December 31, 2011

  $ 24,887  

Foreign currency translation adjustments

    (266
   

 

 

 

Balance at June 30, 2012

  $ 24,621  
   

 

 

 

 

Accrued Warranty

 

                 
    Six Months Ended June 30,  
    2012     2011  

Beginning balance

  $ 258     $ 449  

Product warranties issued

    170       86  

Settlement of warranties

    (120     (155

Change related to preexisting warranties

    (42     —    

Other changes/adjustments

    (1     (76
   

 

 

   

 

 

 

Ending balance

  $ 265     $ 304  
   

 

 

   

 

 

 

Accumulated Other Comprehensive Income

 

                         
    Foreign
Currency
Translation
Adjustment
    Defined Benefit
Pension Plan
    Accumulated
Other
Comprehensive
Income
 

Balance as of December 31, 2011

  $ 14,580     $ (3,950   $ 10,630  

Current period change

    (894     110       (784
   

 

 

   

 

 

   

 

 

 

Balance as of June 30, 2012

  $ 13,686     $ (3,840   $ 9,846  
   

 

 

   

 

 

   

 

 

 
Convertible Debentures
Convertible Debentures

Note 3 – Convertible Debentures

On December 20, 2005, the Company issued $25 million in aggregate principal amount of senior subordinated convertible debentures (the “Debentures”) due and payable in quarterly installments of $2.8 million which commenced December 2008. However, the holder, at its election, could defer each quarterly payment one time, for a 24 month period. As the holder had elected to defer some quarterly installments, the outstanding principal of the Debentures at December 31, 2010 was $8.3 million. In February 2011, the holder of the Debentures converted the remaining $8.3 million principal balance into 514,086 shares of the Company’s common stock at a conversion price of $16.21 per share. On the conversion date, the common stock had a fair value of $9.3 million, which was based on the closing market price. This conversion resulted in a gain of $1.0 million, which is included in “gain on embedded derivatives” in the consolidated statement of operations for the six months ended June 30, 2011.

Interest paid with cash and principal converted into shares of common stock are as follows (in thousands):

 

                 
    Six Months Ended
June 30, 2011
 
    Value     Shares  

Conversion of principal into shares of common stock

  $ 8,333       514  

Interest paid with cash

    17       —    
   

 

 

   

 

 

 

Total debenture payments

  $ 8,350       514  
   

 

 

   

 

 

 

Until the conversion of the remaining principal balance in February 2011, the principal balance was convertible by the holder at any time into common shares. In addition, after eighteen months from the issue date, the Company could have required that a specified amount of the principal of the Debentures be converted if certain conditions were satisfied for a period of 20 consecutive trading days. The Company accounted for the conversion options in the Debentures as derivative liabilities in accordance with the Derivatives and Hedging Topic of the FASB ASC. The discount at the issuance date of $9.2 million related to the fair value of the conversion options and embedded warrants issued in connection with the Debentures, and debt issuance costs, were amortized using the effective interest method over the term of the Debentures. For the six months ended June, 2011, $6,000 of the discount and prepaid fees were amortized. Upon conversion of the remaining principal balance of the Debentures into shares of the Company’s common stock in February 2011, the remaining unamortized discount was written off and is included in “amortization of debt discount and prepaid debt costs” in the consolidated statement of operations.

For the six months ended June 30, 2011, the change in fair value on revaluation of the conversion rights was the difference between the fair value on the conversion date in February 2011 and the fair value at the beginning of the period using the value calculated by the Black-Scholes pricing model. The effect of the fair market value adjustment for six months ended June 30, 2011 was a $78,000 gain, which is recorded as “gain on embedded derivatives” in the consolidated statement of operations.

 

As long as the Debentures were outstanding, the Company was required to maintain a minimum cash balance of $8.0 million. The cash restriction was released in February 2011 when the outstanding principal amount of the convertible debentures was converted to shares of the Company’s common stock.

Credit Facility
Credit Facility

Note 4 – Credit Facility

In December 2011, the Company obtained a secured credit facility in the form of a revolving line of credit up to a maximum of $15.0 million (the “Revolving Line of Credit”) and an equipment term loan up to a maximum of $12.5 million (the “Equipment Term Loan”) (together, the “Credit Facility”). In general, amounts borrowed under the Credit Facility are secured by a lien on all of the Company’s assets other than its intellectual property. The agreement also contains certain restrictive covenants and certain financial covenants that the Company must meet on a quarterly basis during the term of the credit agreement. Borrowings under the Credit Facility bear interest, payable monthly, at either (i) the bank’s prime rate or (ii) LIBOR plus 2.25%, at the Company’s option subject to certain limitations. The Revolving Line of Credit matures on December 5, 2013, and may be prepaid in whole or in part at any time without penalty. On April 30, 2012, the principal amount outstanding under the Equipment Term Loan became payable in 36 equal monthly installments beginning in May 2012 such that the Equipment Term Loan is to be fully repaid by the maturity date of April 30, 2015, but may be prepaid in whole or in part at any time. In March 2012, the Company drew down $5.0 million from the Equipment Term Loan to fund capital expenditures. As of June 30, 2012, $4.9 million was outstanding under the Equipment Term Loan and the applicable interest rate was LIBOR plus 2.25% (2.5% as of June 30, 2012). As of April 30, 2012, the Equipment Term Loan is no longer available for new borrowings. As of June 30, 2012, no amounts were outstanding under the Revolving Line of Credit, therefore, the full amount was available to the Company.

Fair Value Measurements
Fair Value Measurements

Note 5 – Fair Value Measurements

The Company records certain financial instruments at fair value in accordance with the Fair Value Measurements and Disclosures Topic of the FASB ASC. As of June 30, 2012, the financial instruments to which this topic applied were foreign currency forward contracts. As of June 30, 2012, the fair value of these foreign currency forward contracts was a liability of $51,000 which is recorded in “accounts payable and accrued liabilities” in the consolidated balance sheet. The fair value of these derivative instruments is measured using quoted market prices in active markets for identical instruments, which is a Level 1 input under the fair value hierarchy of the Fair Value Measurements and Disclosures Topic of the FASB ASC.

The carrying value of short-term and long-term borrowings approximates fair value because of the relative short maturity of these instruments and the interest rates the Company could currently obtain.

Foreign Currency Derivative Instruments
Foreign Currency Derivative Instruments

Note 6 – Foreign Currency Derivative Instruments

Maxwell uses forward contracts to hedge certain monetary assets and liabilities, primarily receivables and payables, denominated in a foreign currency. The change in fair value of these instruments represents a natural hedge as gains and losses offset the changes in the underlying fair value of the monetary assets and liabilities due to movements in currency exchange rates. These contracts generally expire in one month. These contracts are considered economic hedges and are not designated as hedges under the Derivatives and Hedging Topic of the FASB ASC, therefore, the change in the fair value of the instrument is recognized currently in the consolidated statement of operations.

The net gains and losses on foreign currency forward contracts included in cost of revenue and selling, general and administrative expense are as follows (in thousands):

 

                                 
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2012     2011     2012     2011  
         

Cost of revenue

  $ —       $ (122   $ —       $ (238

Selling, general and administrative

    (1,984     1,958       (1,232     2,015  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total gain (loss)

  $ (1,984   $ 1,836     $ (1,232   $ 1,777  
   

 

 

   

 

 

   

 

 

   

 

 

 

As of June 30, 2012, the total notional amount of foreign currency forward contracts not designated as hedges was $17.3 million. The fair value of these derivatives was a $51,000 liability as of June 30, 2012. For additional information, refer to Note 5 – Fair Value Measurements.

 

The net gains and losses on foreign currency forward contracts were partially offset by net gains and losses on the underlying monetary assets and liabilities. Foreign currency gains and losses on those underlying monetary assets and liabilities included in cost of revenue and selling, general and administrative expense are as follows (in thousands):

 

                                 
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2012     2011     2012     2011  

Cost of revenue

  $ (17   $ 138     $ (1   $ 223  

Selling, general and administrative

    1,993       (2,088     1,125       (2,189
   

 

 

   

 

 

   

 

 

   

 

 

 

Total gain (loss)

  $ 1,976     $ (1,950   $ 1,124     $ (1,966
   

 

 

   

 

 

   

 

 

   

 

 

 
Stock Plans
Stock Plans

Note 7 – Stock Plans

The Company has two active stock-based compensation plans as of June 30, 2012: the 2004 Employee Stock Purchase Plan and the 2005 Omnibus Equity Incentive Plan under which incentive stock options, non-qualified stock options, restricted stock awards and restricted stock units can be granted to employees and non-employee directors.

Stock Options

Compensation expense recognized from employee stock options for the three months ended June 30, 2012 and 2011 was $167,000 and $336,000, respectively, and $712,000 and $815,000 for the six months ended June 30, 2012 and 2011, respectively. Beginning in 2011, the Company ceased granting stock options and began granting restricted stock awards to employees as part of its annual equity incentive award program. The Company may determine to grant stock options in the future under the Incentive Plan.

Restricted Stock Awards

During the three months ended June 30, 2012 and 2011, the Company granted 1,700 and 2,900 shares, respectively, subject to restricted stock awards with an average grant date fair value per share of $8.90 and $16.46, respectively. During the six months ended June 30, 2012 and 2011, the Company granted 251,066 and 215,916 shares, respectively, subject to restricted stock awards with an average grant date fair value per share of $ 20.81 and $18.94, respectively. The following table summarizes the amount of compensation expense recognized for restricted stock awards for the three and six months ended June 30, 2012 and 2011 (in thousands):

 

                                 
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2012     2011     2012     2011  

Service-based restricted stock

  $ 368     $ 234     $ 847     $ 465  

Performance-based restricted stock

    97       90       160       150  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total compensation expense recognized for restricted stock awards

  $ 465     $ 324     $ 1,007     $ 615  
   

 

 

   

 

 

   

 

 

   

 

 

 

Restricted Stock Units

Beginning in 2011, non-employee directors receive an annual restricted stock unit award as part of their annual retainer compensation, which vests one year from the date of grant. During the three months ended June 30, 2012 and 2011, no restricted stock units were granted. During the six months ended June 30, 2012 and 2011, non-employee directors were granted a total of 20,342 and 22,036 restricted stock units, respectively, with an average grant date fair value per share of $20.65 and $19.06, respectively.

Total compensation expense recognized for service-based restricted stock unit awards was $104,000 and $105,000 during the three months ended June 30, 2012 and 2011, respectively, and $210,000 and $163,000 for the six months ended June 30, 2012 and 2011, respectively.

Employee Stock Purchase Plan

The Employee Stock Purchase Plan (“ESPP”) permits substantially all employees to purchase common stock through payroll deductions, at 85% of the lower of the trading price of the stock at the beginning or at the end of each six month offering period commencing on January 1 and July 1. The number of shares purchased is based on participants’ contributions made during the offering period.

Compensation expense recognized for the ESPP for the three months ended June 30, 2012 and 2011 was $34,000 and $24,000, respectively, and $128,000 and $113,000 for the six months ended June 30, 2012 and 2011, respectively. The fair value of the ESPP shares was estimated using the Black-Scholes valuation model for a call and a put option with the following weighted-average assumptions:

 

                 
    Three and Six Months Ended
June 30,
 
    2012     2011  

Expected dividends

  $ —       $ —    

Exercise price

  $ 16.24     $ 18.89  

Expected volatility

    63     48

Average risk-free interest rate

    0.06     0.19

Expected life/term (in years)

    0.5       0.5  

Fair value per share

  $ 5.26     $ 5.51  

 

Stock-based Compensation Expense

Compensation cost for restricted stock, restricted stock units, employee stock options and the ESPP included in cost of revenue; selling, general and administrative expense; and research and development expense is as follows (in thousands):

 

                                 
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2012     2011     2012     2011  

Cost of revenue

  $ 238     $ 84     $ 380     $ 203  

Selling, general and administrative

    411       597       1,374       1,242  

Research and development

    121       108       302       261  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total stock-based compensation expense

  $ 770     $ 789     $ 2,056     $ 1,706  
   

 

 

   

 

 

   

 

 

   

 

 

 
Stock Offering
Stock Offering

Note 8 – Stock Offering

In April 2011, the Company filed a shelf registration statement on Form S-3 with the SEC to, from time to time, sell up to an aggregate of $125 million of our common stock, warrants or debt securities. On August 19, 2011, the registration statement was declared effective by the SEC, which will allow the Company to access the capital markets for the three year period following this effective date. In February 2012, the Company entered into an At-the-Market Equity Offering Sales Agreement (“Sales Agreement”) with Citadel Securities LLC (“Citadel”) pursuant to which the Company may sell, at its option, up to an aggregate of $30.0 million in shares of common stock through Citadel, as sales agent. The Company will pay Citadel a commission equal to 2% of the gross proceeds from the sale of shares of the Company’s common stock under the Sales Agreement. During the three months ended March 31, 2012, 572,510 shares of the Company’s common stock were sold under this Sales Agreement for net proceeds to the Company of $10.3 million. No shares were sold under this Sales Agreement during the three months ended June 30, 2012.

Defined Benefit Plan
Defined Benefit Plan

Note 9 – Defined Benefit Plan

Maxwell SA, a subsidiary of the Company, has a retirement plan that is classified as a defined benefit pension plan. The employee pension benefit is based on compensation, length of service and credited investment earnings. The plan guarantees both a minimum rate of return as well as minimum annuity purchase rates. The Company’s funding policy with respect to the pension plan is to contribute the amount required by Swiss law, using the required percentage applied to the employee’s compensation. In addition, participating employees are required to contribute to the pension plan. This plan has a measurement date of December 31.

Components of net periodic pension cost are as follows (in thousands):

 

                                 
    Three Months
Ended June 30,
    Six Months
Ended June 30,
 
    2012     2011     2012     2011  

Service cost

  $ 168     $ 202     $ 339     $ 388  

Interest cost

    163       182       329       351  

Expected return on plan assets

    (351     (412     (709     (793

Prior service cost amortization

    11       11       22       22  

Deferred loss amortization

    54       79       110       152  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net periodic pension cost

  $ 45     $ 62     $ 91     $ 120  
   

 

 

   

 

 

   

 

 

   

 

 

 

Employer contributions of $183,000 and $200,000 were paid during the three months ended June 30, 2012 and 2011, respectively. Employer contributions of $370,000 and $385,000 were paid during the six months ended June 30, 2012 and 2011, respectively. Additional employer contributions of approximately $311,000 are expected to be paid during the remainder of fiscal 2012.

 

Legal Proceedings
Legal Proceedings

Note 10 – Legal Proceedings

Although the Company expects to incur significant legal costs in connection with the below legal proceedings, the Company is unable to estimate the amount of such legal costs and therefore, such costs will be expensed in the period the legal services are performed.

FCPA Matter

As a result of being a publicly traded company in the U.S., the Company is subject to the U.S. Foreign Corrupt Practices Act (“FCPA”), which prohibits companies from making improper payments to foreign officials for the purpose of obtaining or keeping business. Beginning in 2009, the Company conducted an internal review into payments made to its former independent sales agent in China with respect to sales of the Company’s high voltage capacitor products produced by the Company’s Swiss subsidiary. In January 2011, the Company reached settlements with the SEC and the U.S. Department of Justice (“DOJ”) with respect to charges asserted by the SEC and DOJ relating to the anti-bribery, books and records, internal controls, and disclosure provisions of the FCPA and other securities law violations. The Company settled civil charges with the SEC, agreeing to an injunction against further violations of the FCPA. Under the terms of the settlement with the SEC, the Company agreed to pay a total of $6.4 million in profit disgorgement and prejudgment interest, in two installments, with $3.2 million paid in each of the first quarters of 2011 and 2012. Under the terms of the settlement with the DOJ, the Company agreed to pay a total of $8.0 million in penalties in three installments, with $3.5 million paid in the first quarter of 2011, $2.3 million paid in the first quarter of 2012, and $2.3 million payable in the first quarter of 2013. As part of the settlement, the Company entered into a three-year deferred prosecution agreement (“DPA”) with the DOJ. If the Company remains in compliance with the terms of the DPA, at the conclusion of the term, the charges against the Company asserted by the DOJ will be dismissed with prejudice. Further, under the terms of the agreements, the Company will periodically report to the SEC and DOJ on the Company’s internal compliance program concerning anti-bribery. As of June 30, 2012, the Company has accrued a liability of $2.3 million for this matter, which is included in “accounts payable and accrued liabilities” on the accompanying consolidated balance sheet.

Customer Bankruptcy Matter

In January 2011, the Company attended a bankruptcy proceeding for a previous customer in order to bid on certain intellectual property and physical assets that were being auctioned. During this proceeding, an offer for sale was presented for any and all potential claims held by the previous customer against the Company. These potential claims related primarily to payments made to the Company prior to the previous customer filing bankruptcy, as well as a potential intellectual property dispute between the Company and the previous customer. At the January 2011 bankruptcy proceeding, the Company bid $250,000 to purchase the right to any and all future claims against the Company stemming from rights held by the previous customer. However, following the auction, the previous customer essentially declined this offer for settlement. Since this time, in the interest of a more expedient resolution to this matter, the Company recently increased its settlement offer to $750,000. However, this settlement offer was rejected by the previous customer. The Company believes that it has strong legal defenses against any and all potential claims related to this matter, and does not believe a settlement amount in excess of $750,000 is likely. The Company’s current estimate of the range of loss on this matter is $750,000 to $1,100,000, with the low end of this range based on the Company’s recent settlement offer, and the high end of the range based on the amount the Company expects that the previous customer would immediately accept without further negotiation. The Company has accrued a total of $750,000 as the estimated loss on this matter, which is included in “accounts payable and accrued liabilities” in the consolidated balance sheet as of June 30, 2012.

Description of Business and Basis of Presentation (Policies)

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts and related disclosures. These estimates include, but are not limited to, assessing the collectability of accounts receivable, applied and unapplied production costs, production capacities, the usage and recoverability of inventories and long-lived assets, including deferred income taxes, the incurrence of warranty obligations, impairment of goodwill and other intangible assets, estimation of the cost to complete certain projects, accruals for estimated losses from legal matters, and estimation of the value of stock-based compensation awards, including the probability that the performance criteria of restricted stock awards will be met.

Warranty Obligation

The Company provides warranties on all product sales. The majority of the Company’s warranties are for one to two years in the normal course of business. The Company accrues for the estimated warranty costs at the time of sale based on historical warranty experience plus any known or expected changes in warranty exposure.

Net Income (Loss) per Share

In accordance with the Earnings Per Share Topic of the FASB ASC, basic net income (loss) per share is calculated using the weighted average number of common shares outstanding during the period. Diluted net income per share includes the impact of additional common shares that would have been outstanding if potentially dilutive common shares were issued. Potentially dilutive securities are not considered in the calculation of diluted net loss per share, as their inclusion would be anti-dilutive.

Financial Statement Presentation

The accompanying condensed consolidated financial statements include the accounts of Maxwell Technologies, Inc. and its subsidiaries. All significant intercompany transactions and account balances have been eliminated in consolidation. The Company has prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with the instructions to Form 10-Q and the standards of accounting measurement set forth in the Interim Reporting Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”). Consequently, the Company has not necessarily included in this Form 10-Q all information and footnotes required for audited financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements in this Form 10-Q contain all adjustments (consisting only of normal recurring adjustments, except as otherwise indicated) necessary to present fairly the financial position, results of operations, and cash flows of Maxwell Technologies, Inc. for all periods presented. The results reported in these condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for any subsequent period or for the entire year. These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and the notes thereto included in the Company’s latest Annual Report on Form 10-K. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted in the accompanying interim consolidated financial statements. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.

Change in Additional Paid in Capital

For the six months ended June 30, 2012, additional paid in capital increased $13.3 million. This increase includes $10.2 million related to proceeds from shares of common stock sold pursuant to the Company’s shelf registration statement, net of offering costs, and $3.4 million associated with the Company’s stock-based compensation plans, offset by $318,000 for the repurchase of shares that were withheld by the Company to satisfy employee tax liabilities upon the vesting of restricted stock awards.

Pending Accounting Pronouncements

In December 2011, the FASB issued Accounting Standards Update No. 2011-11, Balance Sheet (Topic 210), Disclosures about Offsetting Assets and Liabilities, which requires companies to disclose information about financial instruments that have been offset and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. Companies will be required to provide both net (offset amounts) and gross information in the notes to the financial statements for relevant assets and liabilities that are offset. This standard will be effective for fiscal years, and interim periods within those years, beginning on or after January 1, 2013. The Company does not expect the adoption of the standard update to impact its financial position or results of operations, as it only requires additional disclosure in the Company’s financial statements.

The Company accounted for the conversion options in the Debentures as derivative liabilities in accordance with the Derivatives and Hedging Topic of the FASB ASC. The discount at the issuance date of $9.2 million related to the fair value of the conversion options and embedded warrants issued in connection with the Debentures, and debt issuance costs, were amortized using the effective interest method over the term of the Debentures.

The Company records certain financial instruments at fair value in accordance with the Fair Value Measurements and Disclosures Topic of the FASB ASC. As of June 30, 2012, the financial instruments to which this topic applied were foreign currency forward contracts. As of June 30, 2012, the fair value of these foreign currency forward contracts was a liability of $51,000 which is recorded in “accounts payable and accrued liabilities” in the consolidated balance sheet. The fair value of these derivative instruments is measured using quoted market prices in active markets for identical instruments, which is a Level 1 input under the fair value hierarchy of the Fair Value Measurements and Disclosures Topic of the FASB ASC.

Description of Business and Basis of Presentation (Tables)

The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share data):

 

                                 
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2012     2011     2012     2011  

Numerator

                               

Net income (loss)

  $ 2,658     $ (1,217   $ 3,162     $ (1,021

Denominator

                               

Weighted-average common shares outstanding

    28,672       27,669       28,397       27,478  

Effect of potentially dilutive securities:

                               

Options to purchase common stock

    85       —         223       —    

Restricted stock awards

    5       —         23       —    

Restricted stock unit awards

    —         —         4       —    

Employee stock purchase plan

    18       —         33       —    
   

 

 

   

 

 

   

 

 

   

 

 

 

Weighted-average common shares outstanding, assuming dilution

    28,780       27,669       28,680       27,478  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per share

                               

Basic

  $ 0.09     $ (0.04   $ 0.11     $ (0.04

Diluted

  $ 0.09     $ (0.04   $ 0.11     $ (0.04

The following table summarizes instruments that may be convertible into common shares that are not included in the denominator used in the diluted net income (loss) per share calculation because to do so would be anti-dilutive (in thousands):

 

                                 
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2012     2011     2012     2011  

Outstanding options to purchase common stock

    637       1,404       318       1,404  

Restricted stock awards

    340       259       238       259  

Restricted stock unit awards

    21       22       —         22  

Employee stock purchase plan

    —         19       —         19  
Balance Sheet Details (Tables)

Inventories

 

                 
    June 30,
2012
    December 31,
2011
 

Raw material and purchased parts

  $ 12,159     $ 10,361  

Work-in-process

    3,014       3,552  

Finished goods

    15,044       13,319  
   

 

 

   

 

 

 

Total inventories

  $ 30,217     $ 27,232  
   

 

 

   

 

 

 

Intangible Assets

Intangible assets consisted of the following:

 

                                 
    Gross
Carrying
Value
    Accumulated
Amortization
    Foreign
Currency
Adjustment
    Net
Carrying
Value
 

As of June 30, 2012:

                               

Patents

  $ 2,476     $ (1,802   $ —       $ 674  

Developed core technology

    1,100       (1,393     299       6  

Patent license agreement

    741       (572     5       174  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total intangible assets at June 30, 2012

  $ 4,317     $ (3,767   $ 304     $ 854  
   

 

 

   

 

 

   

 

 

   

 

 

 
         
    Gross
Carrying
Value
    Accumulated
Amortization
    Foreign
Currency
Adjustment
    Net
Carrying
Value
 

As of December 31, 2011:

                               

Patents

  $ 2,476     $ (1,699   $ —       $ 777  

Developed core technology

    1,100       (1,325     304       79  

Patent license agreement

    741       (494     8       255  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total intangible assets at December 31, 2011

  $ 4,317     $ (3,518   $ 312     $ 1,111  
   

 

 

   

 

 

   

 

 

   

 

 

 

Goodwill

The change in the carrying amount of goodwill from December 31, 2011 to June 30, 2012 is as follows:

 

         

Balance at December 31, 2011

  $ 24,887  

Foreign currency translation adjustments

    (266
   

 

 

 

Balance at June 30, 2012

  $ 24,621  
   

 

 

 

Accrued Warranty

 

                 
    Six Months Ended June 30,  
    2012     2011  

Beginning balance

  $ 258     $ 449  

Product warranties issued

    170       86  

Settlement of warranties

    (120     (155

Change related to preexisting warranties

    (42     —    

Other changes/adjustments

    (1     (76
   

 

 

   

 

 

 

Ending balance

  $ 265     $ 304  
   

 

 

   

 

 

 

Accumulated Other Comprehensive Income

 

                         
    Foreign
Currency
Translation
Adjustment
    Defined Benefit
Pension Plan
    Accumulated
Other
Comprehensive
Income
 

Balance as of December 31, 2011

  $ 14,580     $ (3,950   $ 10,630  

Current period change

    (894     110       (784
   

 

 

   

 

 

   

 

 

 

Balance as of June 30, 2012

  $ 13,686     $ (3,840   $ 9,846  
   

 

 

   

 

 

   

 

 

 
Convertible Debentures (Tables)
Schedule of debenture interest paid with cash and principal converted into shares of common stock

Interest paid with cash and principal converted into shares of common stock are as follows (in thousands):

 

                 
    Six Months Ended
June 30, 2011
 
    Value     Shares  

Conversion of principal into shares of common stock

  $ 8,333       514  

Interest paid with cash

    17       —    
   

 

 

   

 

 

 

Total debenture payments

  $ 8,350       514  
   

 

 

   

 

 

 
Foreign Currency Derivative Instruments (Tables)

The net gains and losses on foreign currency forward contracts included in cost of revenue and selling, general and administrative expense are as follows (in thousands):

 

                                 
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2012     2011     2012     2011  
         

Cost of revenue

  $ —       $ (122   $ —       $ (238

Selling, general and administrative

    (1,984     1,958       (1,232     2,015  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total gain (loss)

  $ (1,984   $ 1,836     $ (1,232   $ 1,777  
   

 

 

   

 

 

   

 

 

   

 

 

 

Foreign currency gains and losses on those underlying monetary assets and liabilities included in cost of revenue and selling, general and administrative expense are as follows (in thousands):

 

                                 
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2012     2011     2012     2011  

Cost of revenue

  $ (17   $ 138     $ (1   $ 223  

Selling, general and administrative

    1,993       (2,088     1,125       (2,189
   

 

 

   

 

 

   

 

 

   

 

 

 

Total gain (loss)

  $ 1,976     $ (1,950   $ 1,124     $ (1,966
   

 

 

   

 

 

   

 

 

   

 

 

 
Stock Plans (Tables)

The fair value of the ESPP shares was estimated using the Black-Scholes valuation model for a call and a put option with the following weighted-average assumptions:

 

                 
    Three and Six Months Ended
June 30,
 
    2012     2011  

Expected dividends

  $ —       $ —    

Exercise price

  $ 16.24     $ 18.89  

Expected volatility

    63     48

Average risk-free interest rate

    0.06     0.19

Expected life/term (in years)

    0.5       0.5  

Fair value per share

  $ 5.26     $ 5.51  

Compensation cost for restricted stock, restricted stock units, employee stock options and the ESPP included in cost of revenue; selling, general and administrative expense; and research and development expense is as follows (in thousands):

 

                                 
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2012     2011     2012     2011  

Cost of revenue

  $ 238     $ 84     $ 380     $ 203  

Selling, general and administrative

    411       597       1,374       1,242  

Research and development

    121       108       302       261  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total stock-based compensation expense

  $ 770     $ 789     $ 2,056     $ 1,706  
   

 

 

   

 

 

   

 

 

   

 

 

 

The following table summarizes the amount of compensation expense recognized for restricted stock awards for the three and six months ended June 30, 2012 and 2011 (in thousands):

 

                                 
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2012     2011     2012     2011  

Service-based restricted stock

  $ 368     $ 234     $ 847     $ 465  

Performance-based restricted stock

    97       90       160       150  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total compensation expense recognized for restricted stock awards

  $ 465     $ 324     $ 1,007     $ 615  
   

 

 

   

 

 

   

 

 

   

 

 

 
Defined Benefit Plan (Tables)
Schedule of components of net periodic pension income

Components of net periodic pension cost are as follows (in thousands):

 

                                 
    Three Months
Ended June 30,
    Six Months
Ended June 30,
 
    2012     2011     2012     2011  

Service cost

  $ 168     $ 202     $ 339     $ 388  

Interest cost

    163       182       329       351  

Expected return on plan assets

    (351     (412     (709     (793

Prior service cost amortization

    11       11       22       22  

Deferred loss amortization

    54       79       110       152  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net periodic pension cost

  $ 45     $ 62     $ 91     $ 120  
   

 

 

   

 

 

   

 

 

   

 

 

 
Description of Business and Basis of Presentation (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Schedule of computation of basic and diluted net income (loss) per share
 
 
 
 
Net income (loss)
$ 2,658 
$ (1,217)
$ 3,162 
$ (1,021)
Effect of assumed conversion of convertible debentures
 
 
 
 
Weighted-average common shares outstanding
28,672 
27,669 
28,397 
27,478 
Weighted-average common shares outstanding, assuming dilution
28,780 
27,669 
28,680 
27,478 
Basic
$ 0.09 
$ (0.04)
$ 0.11 
$ (0.04)
Diluted
$ 0.09 
$ (0.04)
$ 0.11 
$ (0.04)
Outstanding options to purchase common stock [Member]
 
 
 
 
Effect of assumed conversion of convertible debentures
 
 
 
 
Effect of potentially dilutive securities
85 
 
223 
 
Restricted Stock Awards [Member]
 
 
 
 
Effect of assumed conversion of convertible debentures
 
 
 
 
Effect of potentially dilutive securities
 
23 
 
Restricted Stock Unit Awards [Member]
 
 
 
 
Effect of assumed conversion of convertible debentures
 
 
 
 
Effect of potentially dilutive securities
   
 
 
Employee stock purchase plan [Member]
 
 
 
 
Effect of assumed conversion of convertible debentures
 
 
 
 
Effect of potentially dilutive securities
18 
 
33 
 
Description of Business and Basis of Presentation (Details 1)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Outstanding options to purchase common stock [Member]
 
 
 
 
Schedule of instruments convertible into common shares that are not included in the denominator used in the diluted net income (loss) per share calculation because to do so would be anti-dilutive
 
 
 
 
Anti-dilutive, shares
637 
1,404 
318 
1,404 
Restricted Stock Awards [Member]
 
 
 
 
Schedule of instruments convertible into common shares that are not included in the denominator used in the diluted net income (loss) per share calculation because to do so would be anti-dilutive
 
 
 
 
Anti-dilutive, shares
340 
259 
238 
259 
Restricted Stock Unit Awards [Member]
 
 
 
 
Schedule of instruments convertible into common shares that are not included in the denominator used in the diluted net income (loss) per share calculation because to do so would be anti-dilutive
 
 
 
 
Anti-dilutive, shares
21 
22 
 
22 
Employee stock purchase plan [Member]
 
 
 
 
Schedule of instruments convertible into common shares that are not included in the denominator used in the diluted net income (loss) per share calculation because to do so would be anti-dilutive
 
 
 
 
Anti-dilutive, shares
 
19 
 
19 
Description of Business and Basis of Presentation (Details Textual) (USD $)
6 Months Ended
Jun. 30, 2012
Segment
Location
Description of Business and Basis of Presentation (Textual) [Abstract]
 
Manufacturing locations
Operating segments
Additional paid in capital increase
$ 13,300,000 
Additional paid in capital increase related to shares issued for principal payments on convertible debt
10,200,000 
Amount associated with stock-based compensation plans
3,400,000 
Repurchase of shares
$ 318,000 
Maximum [Member]
 
Description of Business and Basis of Presentation (Textual) [Abstract]
 
Warranty period, in years
Minimum [Member]
 
Description of Business and Basis of Presentation (Textual) [Abstract]
 
Warranty period, in years
Balance Sheet Details (Details) (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2012
Dec. 31, 2011
Schedule of inventories
 
 
Raw material and purchased parts
$ 12,159 
$ 10,361 
Work-in-process
3,014 
3,552 
Finished goods
15,044 
13,319 
Total inventories
$ 30,217 
$ 27,232 
Balance Sheet Details (Details 1) (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2012
Dec. 31, 2011
Schedule of intangible assets
 
 
Gross Carrying Value
$ 4,317 
$ 4,317 
Accumulated Amortization
(3,767)
3,518 
Foreign Currency Adjustment
304 
312 
Net Carrying Value
854 
1,111 
Patents [Member]
 
 
Schedule of intangible assets
 
 
Gross Carrying Value
2,476 
2,476 
Accumulated Amortization
(1,802)
1,699 
Net Carrying Value
674 
777 
Developed core technology [Member]
 
 
Schedule of intangible assets
 
 
Gross Carrying Value
1,100 
1,100 
Accumulated Amortization
(1,393)
1,325 
Foreign Currency Adjustment
299 
(304)
Net Carrying Value
79 
Patent license agreement [Member]
 
 
Schedule of intangible assets
 
 
Gross Carrying Value
741 
741 
Accumulated Amortization
(572)
494 
Foreign Currency Adjustment
(8)
Net Carrying Value
$ 174 
$ 255 
Balance Sheet Details (Details 2) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2012
Schedule of change in the carrying amount of goodwill
 
Balance at December 31, 2011
$ 24,887 
Foreign currency translation adjustments
(266)
Balance at June 30, 2012
$ 24,621 
Balance Sheet Details (Details 3) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Schedule of accrued warranty
 
 
Beginning balance
$ 258 
$ 449 
Product warranties issued
170 
86 
Settlement of warranties
(120)
(155)
Change related to preexisting warranties
(42)
 
Other changes/adjustments
(1)
(76)
Ending balance
$ 265 
$ 304 
Balance Sheet Details (Details 4) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Schedule of accumulated other comprehensive income
 
 
 
 
Accumulated Other Comprehensive Income, Balance as of December 31, 2011
 
 
$ 10,630 
 
Accumulated Other Comprehensive Income, Current period change
(3,292)
5,398 
(784)
6,234 
Accumulated Other Comprehensive Income, Balance as of June 30, 2012
9,846 
 
9,846 
 
Defined Benefit Pension Plan [Member]
 
 
 
 
Schedule of accumulated other comprehensive income
 
 
 
 
Defined Benefit Pension Plan, Balance as of December 31, 2011
 
 
(3,950)
 
Defined Benefit Pension Plan, Current period change
 
 
110 
 
Defined Benefit Pension Plan, Balance as of June 30, 2012
(3,840)
 
(3,840)
 
Foreign Currency Translation Adjustment [Member]
 
 
 
 
Schedule of accumulated other comprehensive income
 
 
 
 
Foreign Currency Translation Adjustment, Balance as of December 31, 2011
 
 
14,580 
 
Foreign Currency Translation Adjustment, Current period change
 
 
(894)
 
Foreign Currency Translation Adjustment, Balance as of June 30, 2012
$ 13,686 
 
$ 13,686 
 
Convertible Debentures (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
1 Months Ended 6 Months Ended
Feb. 28, 2011
Jun. 30, 2011
Schedule of debenture interest paid with cash and principal converted into shares of common stock
 
 
Conversion of principal into shares of common stock, Value
$ 8,300 
$ 8,333 
Conversion of principal into shares of common stock, Shares
514,086 
514,000 
Interest paid with cash, Value
 
17 
Total debenture payments
 
$ 8,350 
Convertible Debentures (Details Textual) (USD $)
1 Months Ended 6 Months Ended
Feb. 28, 2011
D
Dec. 20, 2005
Jun. 30, 2012
Jun. 30, 2011
Dec. 31, 2010
Convertible Debentures (Textual) [Abstract]
 
 
 
 
 
Deferment Period for debenture cost
 
 
24 months 
 
 
Number of shares issued in exchange for debentures
514,086 
 
 
514,000 
 
Debentures, principal amount
 
$ 25,000,000 
 
 
 
Quarterly installment amount
 
2,800,000 
 
 
 
Debentures, outstanding amount
 
 
 
 
8,300,000 
Conversion of principal into shares of common stock, Value
8,300,000 
 
 
8,333,000 
 
Debentures converted into common stock, conversion price per share
$ 16.21 
 
 
 
 
Common stock fair value on the date of conversion of debentures
9,300,000 
 
 
 
 
Gain (loss) on embedded derivatives and warrants
1,000,000 
 
 
78,000 
 
Number of trading days
20 
 
 
 
 
Minimum cash balance required to maintain
8,000,000 
 
 
 
 
Amortized discount and prepaid fees
 
 
 
6,000 
 
Debt instrument original discount and issuance costs
$ 9,200,000 
 
 
 
 
Credit Facility (Details Textual) (USD $)
6 Months Ended
Jun. 30, 2012
Dec. 31, 2011
Line of Credit Facility [Line Items]
 
 
Borrowings under credit facility, interest payable description
at either (i) the bank’s prime rate or (ii) LIBOR plus 2.25% 
 
Credit Facility (Textual) [Abstract]
 
 
Borrowings under credit facility, interest related to Libor rate
2.25% 
 
Credit facility, total
$ 0 
 
Revolving Credit Facility [Member]
 
 
Line of Credit Facility [Line Items]
 
 
Revolving line of credit
 
15,000,000 
Revolving line of credit, maturity date
Dec. 05, 2013 
 
Secured Debt [Member]
 
 
Line of Credit Facility [Line Items]
 
 
Equipment term loan
 
12,500,000 
Borrowings under credit facility, interest payable description
applicable interest rate was LIBOR plus 2.25% (2.5% as of June 30, 2012) 
 
Revolving line of credit, maturity date
Apr. 30, 2015 
 
Equipment term loan payable term
36 months 
 
Equipment term loan, outstanding
4,900,000 
 
Equipment term loan, interest rate
2.50% 
 
Equipment term loan, drew down to fund capital expenditures
$ 5,000,000 
 
Fair Value Measurements (Details Textual) (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2012
Dec. 31, 2011
Fair Value Measurements (Textual) [Abstract]
 
 
Accounts payable and accrued liabilities
$ 32,301 
$ 37,145 
Foreign Currency Derivative Instruments (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Schedule of gains (losses) on foreign currency forward contracts
 
 
 
 
Net gains (losses) on foreign currency forward contracts
$ (1,984)
$ 1,836 
$ (1,232)
$ 1,777 
Cost of revenue [Member]
 
 
 
 
Schedule of gains (losses) on foreign currency forward contracts
 
 
 
 
Net gains (losses) on foreign currency forward contracts
 
(122)
 
(238)
Selling, general and administrative [Member]
 
 
 
 
Schedule of gains (losses) on foreign currency forward contracts
 
 
 
 
Net gains (losses) on foreign currency forward contracts
$ (1,984)
$ 1,958 
$ (1,232)
$ 2,015 
Foreign Currency Derivative Instruments (Details 1) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Schedule of foreign currency gains and losses on underlying assets and liabilities
 
 
 
 
Net gains and losses on foreign currency forward contracts were partially offset on assets and liabilities
$ 1,976 
$ (1,950)
$ 1,124 
$ (1,966)
Cost of revenue [Member]
 
 
 
 
Schedule of foreign currency gains and losses on underlying assets and liabilities
 
 
 
 
Net gains and losses on foreign currency forward contracts were partially offset on assets and liabilities
(17)
138 
(1)
223 
Selling, general and administrative [Member]
 
 
 
 
Schedule of foreign currency gains and losses on underlying assets and liabilities
 
 
 
 
Net gains and losses on foreign currency forward contracts were partially offset on assets and liabilities
$ 1,993 
$ (2,088)
$ 1,125 
$ (2,189)
Foreign Currency Derivative Instruments (Details Textual) (USD $)
Jun. 30, 2012
Foreign Currency Derivative Instruments (Textual) [Abstract]
 
Notional amount of foreign currency forward contracts not designated as hedges
$ 17,300,000 
Fair value of derivatives (liability)
$ 51,000 
Stock Plans (Details) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Schedule of stock-based compensation expense
 
 
 
 
Stock-based compensation expense
$ 770,000 
$ 789,000 
$ 2,056,000 
$ 1,706,000 
Restricted Stock Awards [Member]
 
 
 
 
Schedule of stock-based compensation expense
 
 
 
 
Stock-based compensation expense
465,000 
324,000 
1,007,000 
615,000 
Service-based restricted stock [Member] |
Restricted Stock Awards [Member]
 
 
 
 
Schedule of stock-based compensation expense
 
 
 
 
Stock-based compensation expense
368,000 
234,000 
847,000 
465,000 
Performance-based restricted stock [Member] |
Restricted Stock Awards [Member]
 
 
 
 
Schedule of stock-based compensation expense
 
 
 
 
Stock-based compensation expense
97,000 
90,000 
160,000 
150,000 
Cost of revenue [Member]
 
 
 
 
Schedule of stock-based compensation expense
 
 
 
 
Stock-based compensation expense
238,000 
84,000 
380,000 
203,000 
Selling, general and administrative [Member]
 
 
 
 
Schedule of stock-based compensation expense
 
 
 
 
Stock-based compensation expense
411,000 
597,000 
1,374,000 
1,242,000 
Research and development [Member]
 
 
 
 
Schedule of stock-based compensation expense
 
 
 
 
Stock-based compensation expense
$ 121,000 
$ 108,000 
$ 302,000 
$ 261,000 
Stock Plans (Details 1) (Employee Stock Purchase Plan [Member], USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Employee Stock Purchase Plan [Member]
 
 
 
 
Schedule of stock options and employee stock purchase plan weighted-average assumptions
 
 
 
 
Expected dividends
   
   
   
   
Exercise price
$ 16.24 
$ 18.89 
$ 16.24 
$ 18.89 
Expected volatility
63.00% 
48.00% 
63.00% 
48.00% 
Average risk-free interest rate
0.06% 
0.19% 
0.06% 
0.19% 
Expected life/term (in years)
6 months 
6 months 
6 months 
6 months 
Fair value per share
$ 5.26 
$ 5.51 
$ 5.26 
$ 5.51 
Stock Plans (Details Textual) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2012
Stockcompensationplan
Jun. 30, 2011
Jun. 30, 2012
Stockcompensationplan
Jun. 30, 2011
Stock Plans (Textual) [Abstract]
 
 
 
 
Stock-based compensation plans
 
 
Stock-based compensation expense
$ 770,000 
$ 789,000 
$ 2,056,000 
$ 1,706,000 
Outstanding options to purchase common stock [Member]
 
 
 
 
Stock Plans (Textual) [Abstract]
 
 
 
 
Stock-based compensation expense
167,000 
336,000 
712,000 
815,000 
Restricted Stock Awards [Member]
 
 
 
 
Stock Plans (Textual) [Abstract]
 
 
 
 
Restricted stock granted
1,700 
2,900 
251,066 
215,916 
Restricted stock unit, average grant date fair value per share
$ 8.90 
$ 16.46 
$ 20.81 
$ 18.94 
Restricted Stock Unit [Member]
 
 
 
 
Stock Plans (Textual) [Abstract]
 
 
 
 
Stock-based compensation expense
104,000 
105,000 
210,000 
163,000 
Restricted stock unit, granted
20,342 
22,036 
Restricted stock unit, average grant date fair value per share
$ 0.00 
$ 0.00 
$ 20.65 
$ 19.06 
Restricted stock unit vesting period (in years)
 
 
1 year 
 
Employee Stock Purchase Plan [Member]
 
 
 
 
Stock Plans (Textual) [Abstract]
 
 
 
 
Stock-based compensation expense
$ 34,000 
$ 24,000 
$ 128,000 
$ 113,000 
Discount rate from market value on offering date
 
 
85.00% 
 
Stock Offering (Details Textual) (USD $)
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 29, 2012
Jun. 30, 2012
Mar. 31, 2012
Jun. 30, 2012
Stock Offering (Textual) [Abstract]
 
 
 
 
Sale of common stock shares
 
 
 
$ 125,000,000 
Capital market access period
 
 
 
3 years 
Stock offering common stock warrants
30,000,000 
 
 
 
Commission on sale of common stock
 
 
 
2.00% 
Common stock sold, shares
 
572,510 
 
Net proceeds on sale of common stock
 
 
$ 10,283,000 
$ 10,283,000 
Number of shares sold under sales agreement
 
572,510 
 
Defined Benefit Plan (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Schedule of components of net periodic pension income
 
 
 
 
Service cost
$ 168 
$ 202 
$ 339 
$ 388 
Interest cost
163 
182 
329 
351 
Expected return on plan assets
(351)
(412)
(709)
(793)
Prior service cost amortization
11 
11 
22 
22 
Deferred loss amortization
54 
79 
110 
152 
Net periodic pension income
$ 45 
$ 62 
$ 91 
$ 120 
Defined Benefit Plan (Details Textual) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Defined Benefit Plan (Textual) [Abstract]
 
 
 
 
Employer contributions
$ 183,000 
$ 200,000 
$ 370,000 
$ 385,000 
Additional employer contributions, expected to be paid during the remainder of fiscal year
$ 311,000 
 
$ 311,000 
 
Legal Proceedings (Details Textual) (USD $)
6 Months Ended
Jun. 30, 2012
Jan. 31, 2011
Legal proceedings (Textual) [Abstract]
 
 
Profit disgorgement and prejudgment interest
$ 6,400,000 
 
Profit disgorgement and prejudgment interest paid
3,200,000 
 
Profit disgorgement and prejudgment interest payable in 2012
3,200,000 
 
Penalties under the terms of the settlement
8,000,000 
 
Settlement, penalties paid
3,500,000 
 
Settlement, penalties payable in 2012
2,300,000 
 
Settlement, penalties payable in 2013
2,300,000 
 
Penalties under terms of settlement included in accounts payable and accrued liabilities
2,300,000 
 
Customer bankruptcy matter purchase right to future claims
 
250,000 
Customer bankruptcy matter recently increased settlement offer
750,000 
 
Customer bankruptcy matter company maximum settlement offer
1,100,000 
 
Customer bankruptcy matter company minimum settlement offer
750,000 
 
Accrued estimated loss on settlement offer
$ 750,000